• SENSEX
    NIFTY 50
Market

AstraZeneca Pharma stock plunges over 13% after firm pauses COVID vaccine trial

Updated : September 09, 2020 12:12 PM IST

In a statement issued Tuesday evening, the company said its standard review process triggered a pause to vaccination to allow review of safety data.
AstraZeneca Pharma stock plunges over 13% after firm pauses COVID vaccine trial

You May Also Like

Live TV
Advertisement